Danaher Co. (NYSE:DHR) Shares Sold by Sanibel Captiva Trust Company Inc.

Sanibel Captiva Trust Company Inc. reduced its holdings in Danaher Co. (NYSE:DHR) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 15,601 shares of the conglomerate’s stock after selling 753 shares during the quarter. Sanibel Captiva Trust Company Inc.’s holdings in Danaher were worth $3,198,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter worth about $27,000. Golden State Wealth Management LLC acquired a new stake in Danaher in the 4th quarter worth about $31,000. Hurley Capital LLC acquired a new stake in Danaher in the 4th quarter worth about $34,000. Pineridge Advisors LLC lifted its stake in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares in the last quarter. Finally, Rialto Wealth Management LLC purchased a new position in Danaher in the 4th quarter worth approximately $34,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on DHR. Wells Fargo & Company decreased their target price on shares of Danaher from $240.00 to $210.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 23rd. Robert W. Baird decreased their target price on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. UBS Group decreased their target price on shares of Danaher from $275.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 23rd. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research report on Friday, March 14th. Finally, TD Cowen lifted their price target on shares of Danaher from $240.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average price target of $248.17.

Danaher Stock Performance

NYSE:DHR opened at $202.63 on Wednesday. The company has a fifty day simple moving average of $191.32 and a two-hundred day simple moving average of $211.72. The company has a market cap of $145.02 billion, a price-to-earnings ratio of 38.38, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.63%. Danaher’s payout ratio is currently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.